Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
University of Cincinnati National Institute of Neurological Disorders and Stroke (NINDS) |
---|---|
Information provided by: | University of Cincinnati |
ClinicalTrials.gov Identifier: | NCT00642213 |
Our primary goal is to study temporal trends in the incidence rate, causes, treatment, and outcome of stroke among a large biracial metropolitan population of 1,349,351, of whom 215,611 (15%) are black (2000 Census). Such data are critical for the planning, intervention, and evaluation of public health efforts to decrease the mortality and morbidity due to stroke in the United States.
For 1/1/2005 to 12/31/2005, we will identify every hospitalized or autopsied stroke and transient ischemic attack (TIA) at all 17 regional hospitals. We will also estimate the number of non-hospitalized strokes and TIAs by screening for potential cases at 143 outpatient sites throughout five counties in Greater Cincinnati/Northern Kentucky. We plan to identify and abstract detailed information from the medical record for every potential case. These results will be compared with data from all stroke patients identified by the same methodology used during 1993-94 and 1999 as well as with cases of intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH) identified during 1988.
In addition, we will interview 500 ischemic stroke patients and/or their families, to obtain detailed information including demographic information, functional outcome and quality of life, access to and type of rehabilitation therapy, social support, caregiver availability and health status, access to post-hospital care, health insurance status, current health status, medications, prior risk factors, and knowledge about stroke signs and symptoms. We will also obtain genetic material via a blood sample.
Condition |
---|
Ischemic Stroke TIA Hemorrhage |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites: A Population-Based Study in Cincinnati, Ohio |
We have a prospectively collected cohort of 502 of which 450 provided a blood sample for DNA to be processed and stored at Coriell.
Enrollment: | 502 |
Study Start Date: | July 2004 |
Estimated Study Completion Date: | June 2009 |
Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
1
We prospectively collected 502 ischemic stroke patients who could agree to provide a sample for DNA (450). The cohort data consists of a baseline interview, medical record abstraction and a 3m and 12m followup interview.
|
2
The second part of the study is a retrospective medical record review of all potential ischemic strokes, TIAs, and Hemorrhagic strokes in our 5 county region that occurred in the year 2005.
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Prospective cohort:Ischemic stroke patient in 2005 that resides in the GCNK area.
Inclusion Criteria:
Exclusion Criteria:
United States, Ohio | |
University of Cincinnati | |
Cincinnati, Ohio, United States, 45267-0525 |
Principal Investigator: | Brett M Kissela, MD | University of Cincinnati |
Responsible Party: | University of Cincinnati, Dept. of Neurology ( Brett Kissela, M.D. ) |
Study ID Numbers: | NS30678, NIH GRANT:NS30678 |
Study First Received: | March 19, 2008 |
Last Updated: | March 19, 2008 |
ClinicalTrials.gov Identifier: | NCT00642213 History of Changes |
Health Authority: | United States: Institutional Review Board |
stroke ischemic TIA hemorrhage |
incidence case-fatality risk factors genetic |
Radiation-Protective Agents Antioxidants Cerebral Infarction Stroke Hydroquinone Vascular Diseases Central Nervous System Diseases |
Ischemia Hemorrhage Brain Diseases Cerebrovascular Disorders Brain Ischemia Brain Infarction Infarction |
Radiation-Protective Agents Antioxidants Molecular Mechanisms of Pharmacological Action Cerebral Infarction Physiological Effects of Drugs Hydroquinone Stroke Nervous System Diseases Vascular Diseases Central Nervous System Diseases |
Ischemia Hemorrhage Brain Diseases Protective Agents Cerebrovascular Disorders Pharmacologic Actions Pathologic Processes Brain Ischemia Cardiovascular Diseases Brain Infarction |